Early Impact of the Affordable Care Act on Uptake of Long-acting Reversible Contraceptive Methods
Dados Bibliográficos
| ID | 9101348 |
|---|---|
| Autores | Lydia E Pace (0000-0002-5378-0296, Department of Internal Medicine, Division of Women’s Health, Brigham and Women’s Hospital, Boston, MA, autor correspondente), Stacie B Dusetzina (0000-0002-3907-9196, Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy), Nancy L Keating (0000-0002-8274-4681, Department of Internal Medicine, Division of General Internal Medicine, Brigham and Women’s Hospital) |
| Ano | 2016 |
| Volume | 54 |
| Fascículo | 9 |
| Páginas | 811-817 |
| Data de publicação | 2016-09-01 |
| Peer Reviewed | Sim |
| Open Access | Não |
| Tipo | ARTICLE |
| Periódico | Medical Care (JOURNAL) |
| Identificadores do periódico | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editora | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/mlr.0000000000000551 |
| PMID | 27213549 |
| OpenAlex | W2399632312 |
| Idioma | EN |
| Citações recebidas | 14 |
| Referências citadas | 26 |
BACKGROUND: The Affordable Care Act (ACA) required most private insurance plans to cover contraceptive services without patient cost-sharing as of January 2013 for most plans. Whether the ACA's mandate has impacted long-acting reversible contraceptives (LARC) use is unknown. OBJECTIVE: The aim of this article is to assess trends in LARC cost-sharing and uptake before and one year after implementation of the ACA's contraceptive mandate. DESIGN: A retrospective cohort study using Truven Health MarketScan claims data from January 2010 to December 2013. SUBJECTS: Women aged 18-45 years with continuous insurance coverage with claims for oral contraceptive pills, patches, rings, injections, or LARC during 2010-2013 (N=3,794,793). MEASURES: Descriptive statistics were used to assess trends in LARC cost-sharing and uptake from 2010 through 2013. Interrupted time series models were used to assess the association of time, ACA, and time after the ACA on LARC cost-sharing and initiation rates, adjusting for patient and plan characteristics. RESULTS: The proportion of claims with $0 cost-sharing for intrauterine devices and implants, respectively, rose from 36.6% and 9.3% in 2010 to 87.6% and 80.5% in 2013. The ACA was associated with a significant increase in these proportions and in their rate of increase (level and slope change both P<0.001). LARC uptake increased over time with no significant change in level of LARC use after ACA implementation in January 2013 (P=0.44) and a slightly slower rate of growth post-ACA than previously reported (β coefficient for trend, -0.004; P<0.001). CONCLUSIONS: The ACA has significantly decreased LARC cost-sharing, but during its first year had not yet increased LARC initiation rates
Cohort · Cost sharing · Environmental health · Family medicine · Family planning · Health care · Health insurance · Intrauterine device · Long-acting reversible contraception · Mandate · Patient Protection and Affordable Care Act · Pill · Population · Research methodology · Demography · Global Maternal and Child Health · Healthcare Policy and Management · Internal Medicine · Medicine · Nursing · Reproductive Health and Contraception
Motivations for Interest, Disinterest and Uncertainty in Intrauterine Device Use Among Young Women
Prescription Contraceptive Sales Following the Affordable Care Act
Long-Acting Reversible Contraceptive Uptake before and after the Affordable Care Act Contraceptive Mandate in Women Undergoing First Trimester Surgical Abortion
The Impact of the Affordable Care Act on Contraceptive Use and Costs among Privately Insured Women
The Relationship Between Insurance Coverage and Use of Prescription Contraception by Race and Ethnicity
What Women Want
Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania
Advancing Sex- and Gender-Informed Approaches to Health in an Academic Medical Center
Cost Sharing and Utilization of Postpartum Intrauterine Devices and Contraceptive Implants Among Commercially Insured Women
Privately Insured Women’s Expectations of Contraceptive Access without the Affordable Care Act and the Influence of State Contraceptive Equity Protections
Policy impacts on contraceptive access in the United States
Long-Acting Reversible Contraception Free of Charge, Method Initiation, and Abortion Rates in Finland
Effect of Providing Contraception Free of Charge
Impact of Medicaid Eligibility Changes on Long-acting Reversible Contraception Use in Massachusetts and Maine
Effectiveness of Long-Acting Reversible Contraception
The Contraceptive CHOICE Project
Declines in Unintended Pregnancy in the United States, 2008–2011
Segmented regression analysis of interrupted time series studies in medication use research
Preventing Unintended Pregnancies by Providing No-Cost Contraception
Changes in use of long-acting contraceptive methods in the United States, 2007–2009
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
How to do (or not to do) ... Assessing the impact of a policy change with routine longitudinal data
Cost of Contraceptive Methods to Privately Insured Women in the United States
Women's Awareness of, Interest in, and Experiences with Long-acting Reversible and Permanent Contraception
Game Change in Colorado
Women’s Awareness of Their Contraceptive Benefits Under the Patient Protection and Affordable Care Act
The Impact of Out-of-Pocket Costs on the Use of Intrauterine Contraception Among Women With Employer-sponsored Insurance
| Obras citantes distintas | 14 |
|---|---|
| Citações por ano | 1,56 |
| Intervalo de citações | 2017 - 2023 (7) |
| Velocidade de citação | historical |
| Altamente citado | Não |
| Tipos de citação | Neutras: 14 |